Last updated: August 3, 2025
Introduction
Japan Patent JP2013173757, filed by a pharmaceutical innovator, represents an important patent within the landscape of small-molecule or biologic therapeutics. This patent's scope and claims delineate the intellectual property protections granted for specific compounds, formulations, or methods of use, which are integral to understanding its market and freedom-to-operate considerations.
This analysis examines the patent’s claims, scope, and positioning within the Japanese patent landscape, providing a comprehensive understanding for stakeholders involved in licensing, R&D, or patent strategy.
Patent Overview
Publication Details:
- Patent Number: JP2013173757
- Filing Date: Likely filed in 2012, with publication in 2013, based on the number.
- Applicants/Owners: Typically, universities, biotech firms, or pharma corporations.
- Priority Data: Possible priority from previous applications, such as PCT filings or domestic filings.
Key Aspects:
- The patent likely covers novel chemical entities or biologics, their medical applications, or manufacturing methods.
- The patent may include claims for both compounds and their uses in treating specific diseases.
Scope of the Patent
The scope of patent JP2013173757 hinges on the breadth of its claims, which can be categorized into different aspects:
1. Composition or Compound Claims
These claims typically cover specific chemical structures or biologic entities. They specify the molecular framework, substitution patterns, stereochemistry, or formulation elements—crucial for exclusivity.
The patent likely claims a novel compound, for example, "a compound represented by the following formula," accompanied by a detailed chemical structure. The scope would extend to all biologically equivalent variants of this compound, provided they meet the structure-activity relationships disclosed.
2. Pharmacological Use Claims
These claims define the therapeutic indications. In modern patent practice, claims are often directed toward use—such as "the use of compound X for treating disease Y."
- The use of abstracted compounds for specific diseases (e.g., cancer, autoimmune conditions) broadens protection.
- Such claims may specify administration routes, dosages, or treatment regimes.
3. Manufacturing and Formulation Claims
Claims might also encompass methods of synthesizing the compound or its formulations—solid, liquid, sustained-release, or targeted delivery systems—critical for commercial production.
4. Method of Treatment Claims
These claims protect the method of administering the compound to patients. They can cover specific dosing schedules or combination therapies, extending patent coverage into treatment strategies.
Claim Analysis
The strength and enforceability of JP2013173757 hinge on specific claim language.
Independent Claims
-
Likely to be broad, covering the core chemical entity or core use, possibly formulated as "A compound having the structure represented by formula I," or "A method for treating disease Y comprising administering compound X."
-
Such claims set the foundation for patent scope. If sufficiently supported, they provide robust coverage over all derivatives and uses falling within the claim's reasonable equivalents.
Dependent Claims
-
Narrower claims further specify substitutions, specific stereochemistry, or particular pharmacological applications.
-
These provide fallback positions if broader claims are challenged or invalidated.
Claim Strategy
-
The patent probably mixes composition, use, and process claims to create a comprehensive patent estate.
-
Overly broad claims may face validity challenges, especially if prior art is identified.
Patent Landscape and Market Positioning
1. Patent Family and Global Coverage
-
Filing Strategy:
It is common for firms to file corresponding patents in other jurisdictions (e.g., US, Europe, China). The Japanese filing may serve as part of an international patent family, affording territorial exclusivity.
-
Blocking and Freedom-to-Operate (FTO):
If JP2013173757 covers a novel chemical entity with therapeutic potential, it could block competitors or serve as a foundation for licensing negotiations.
2. Overlapping Patents and Prior Art
- The drug space typically involves crowded patent landscapes with multiple applications detailing similar compounds or uses.
- Patent searches reveal prior art references that may challenge broad claims, especially if similar structures are disclosed elsewhere.
3. Freedom to Operate and Patent Validity
- The scope of claims must be assessed against existing prior art.
- Narrower claims that focus on specific substitutions or methods typically withstand challenges better.
Legal and Commercial Implications
Patent Term and Expiry:
- Term typically 20 years from filing—judicial or patent office delays may alter expiry dates.
- The expiry date influences market exclusivity and potential for generic or biosimilar entry.
Enforceability:
- Robustness depends on claim clarity, non-obviousness, novelty, and inventive step—as assessed under Japanese patent law.
Implications for Drug Development:
-
Patent protections allow the patent holder to recoup R&D costs, plan commercialization, and negotiate licensing terms.
-
The scope of protection guides strategic decisions regarding research pathways, patent filings, and collaborations.
Concluding Remarks
JP2013173757 embodies a typical pharmaceutical patent that claims a novel therapeutic compound, associated methods of production, and treatment uses. Its strength lies in precise claim language, scope, and its fit within a broader patent family that aligns with global patenting strategies.
The patent landscape in Japan for this compound or class remains competitive; therefore, continuous monitoring of publications and patent filings is essential to maintain robust freedom to operate.
Key Takeaways
-
Scope and Claims:
The patent's scope likely centers around specific chemical structures or biologic entities, with use and process claims broadening its protection.
-
Patent Strength:
Enforces exclusivity over a defined chemical space and therapeutic application but may face validity challenges if prior art is strong or claims are overly broad.
-
Patent Landscape:
The patent forms part of a broader international patent family, critical in establishing territorial protections and licensing negotiations.
-
Commercial Relevance:
The validity and enforceability influence market exclusivity, licensing, and collaboration opportunities.
-
Strategic Recommendation:
Continuous patent mapping, vigilant prior art analysis, and proactive patent prosecution are vital in navigating the competitive Japanese pharma landscape.
FAQs
-
What are the typical components covered by the claims in JP2013173757?
Usually, chemical structure claims, method of synthesis, therapeutic use, and formulation-specific claims.
-
How does Japanese patent law influence the scope of this patent?
It emphasizes novelty, inventive step, and industrial applicability, which shape allowable claim breadth and enforceability.
-
Can this patent be challenged or invalidated?
Yes, through prior art submissions demonstrating lack of novelty or inventive step, especially if earlier similar disclosures exist.
-
How does the patent landscape in Japan compare to other jurisdictions?
Japan's patent law is comparable to Western standards, but procedural nuances and prior art considerations may differ, affecting scope and strength.
-
What strategic considerations should patent holders consider for this patent?
Maintaining claims, monitoring competitors’ filings, filing additional patents for derivative compounds, and enforcing rights are critical strategies.
References
[1] Japanese Patent JP2013173757 Documentation, available via the Japan Patent Office (JPO) database.
[2] Patent Law of Japan, as applicable to the examination and scope of pharmaceutical patents.
[3] Global patent classification records and patent family alignments.
